ClinicalTrials.gg
Not yet recruitingNCT06489938Updated Jul 8, 2024

Mirror Therapy Combined With Task- vs. Impairment-oriented Rehabilitation Program

An interventional study of Mirror therapy and Task-oriented approach in Cardiovascular Diseases, Stroke and Cerebrovascular Disorders, sponsored by I-Shou University. Not yet recruiting. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-07-08.

Primary conditionStrokeRegistry: Cardiovascular DiseasesReclassifiedWhy we changed it
Registry
Cardiovascular Diseases — the first condition term the registry derived for this study.
ClinicalTrials.gg
Stroke
Why
  1. The study's listed conditions name Stroke, a narrower term within Cardiovascular Diseases.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by I-Shou University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
123
Allocation
Randomized
Ages
20 Years to 80 Years
Sex
All
01

Study summary

The goal of this clinical trial is to examine the effects of mirror therapy combined with task- vs. Impairment-oriented rehabilitation programs as novel hybrid approaches in individuals with stroke. Participants will receive mirror therapy combined with the task-oriented rehabilitation program (MTT), mirror therapy combined with the impairment-oriented rehabilitation program (MTI), or task-oriented rehabilitation program combined with the impairment-oriented rehabilitation program (TI) 90 minutes per day, three days per week, for six weeks.

02

Conditions studied

  • Cardiovascular Diseases
  • Stroke
  • Cerebrovascular Disorders

Browse trials for

Keywords

  • Rehabilitation
  • Mirror Therapy
03

In context

Stroke Reclassified

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

This study's planned enrollment of 123 is above the median of 48 across 6,049 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

I-Shou University is the lead sponsor of 6 studies on the registry; 3 are open to participants now.

Compared within Stroke, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Cardiovascular Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. A first-ever unilateral stroke ≥3 months
  2. Age between 20 and 80 years
  3. Baseline Fugl-Meyer Assessment Upper Extremity (FMA-UE) score >10
  4. No severe spasticity in any joints of the affected arm
  5. Ability to follow the instructions
  6. No participation in other studies during the study period
  7. Willingness to provide informed written consent.

Exclusion criteria

Exclusion Criteria:

  1. Serious medical problems or poor physical conditions that might be detrimental to study participation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
123 participants (estimated)

Study arms

  • Experimental
    Mirror therapy combined with the task-oriented approach (MTT)

    Each participant will receive the mirror therapy combined with the task-oriented approach 90 minutes daily, three days per week for six weeks.

    Behavioral: Mirror therapy · Behavioral: Task-oriented approach

  • Experimental
    Mirror therapy combined with the impairment-oriented approach (MTI)

    Each participant will receive the mirror therapy combined with the impairment-oriented approach 90 minutes daily, three days per week for six weeks.

    Behavioral: Mirror therapy · Behavioral: Impairment-oriented approach

  • Active comparator
    Task-oriented rehabilitation program combined with impairment-oriented rehabilitation program (TI)

    Each participant will receive the task-oriented rehabilitation program combined with the impairment-oriented rehabilitation program 90 minutes daily, three days per week for six weeks.

    Behavioral: Task-oriented approach · Behavioral: Impairment-oriented approach

Interventions

  • BehavioralMirror therapy

    In mirror therapy, a wooden mirror (41×50×33 cm3) will be positioned in the participant's sagittal midplane, blocking the participant's view of the affected arm performance. We will also provide a foldable bed tray table to ensure that the participants focus on the mirror reflection of the less affected arm. The mirror therapy will consist of movement and functional practices.

  • BehavioralTask-oriented approach

    The task-oriented approach will provide both bimanual common-goal and dual-goal tasks for the participants.

  • BehavioralImpairment-oriented approach

    The impairment-oriented approach will focus on the movement components. Arm BASIS or Arm Ability training will be provided based on the severity of the participant's impairment.

06

What researchers measure

Primary outcomes

  1. Fugl-Meyer Assessment

    A standardized tool for evaluating motor impairment for stroke

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

  2. Revised Nottingham Sensory Assessment

    A standardized tool for evaluating sensory impairment for stroke

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

  3. Chedoke Arm and Hand Activity Inventory

    An assessment for bilateral functional abilities

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

  4. Wolf Motor Function Test

    An assessment for both unilateral and bilateral functional abilities

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

Secondary outcomes

  1. Grip and pinch power

    The measurements of the strength of hand movements

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

  2. Box and block test

    A measurement for evaluating functional hand use by measuring the number of blocks moved within a set time

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

  3. Ten-meter walk test

    A test for measuring walking speed and stride length over a fixed distance to assess mobility and functional status

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

  4. Berg Balance Scale

    A measurement for evaluating balance abilities through a series of functional tasks

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

  5. Motor Activity Log

    A self-report tool used to assess the amount and quality of use of an affected limb during daily activities

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

  6. ABILHAND Questionnaire

    A self-reported assessment tool used to measure manual ability by evaluating their perceived difficulty in performing bimanual tasks

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

  7. Functional independent measure

    An assessment tool that evaluates a person's level of disability and functional independence in performing daily activities, covering areas such as self-care, mobility, communication, and social cognition

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

  8. Nottingham Extended Activities of Daily Living Scale

    An assessment tool designed to measure a person's ability to perform daily activities

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

  9. Stoke Impact Scale

    A comprehensive self-reported questionnaire that assesses the impact of a stroke on life

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

  10. Stroke Self-Efficacy Questionnaire

    A tool used to evaluate a stroke survivor's confidence to perform daily activities

    Time frame: Baseline, six weeks, and 3 months after completing the intervention

  11. Stroke-Specific Measure of Adherence to Home-based Exercises

    A questionnaire designed to assess how consistently stroke participations follow prescribed home programs

    Time frame: Six weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2024; primary completion for Dec 2030, 77 months later.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 77 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 29, 2024
First posted
Jul 8, 2024
StartEst.
Jul 1, 2024
Primary completionEst.
Dec 31, 2030
CompletionEst.
Dec 31, 2030
Last update
Jul 8, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06489938
Lead sponsor
I-Shou University
Responsible party
Yi-chun Li (Neuro-Rehabilitation Research Laboratory (NRRL), I-Shou University) — Principal investigator
First posted
Jul 8, 2024
Start date
Jul 1, 2024 (estimated)
Primary completion
Dec 31, 2030 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Jul 8, 2024

Study contacts

Yi-chun Li, Doctor
Contact
joyjoyfish@gmail.com
+886-7-6151100 ext. 7514
Yi-chun Li, Doctor
principal investigator · I-Shou University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion